Intratech Medical is a company focused on developing medical devices for cardiovascular interventions. They are currently working on the Booster™ spiral balloon device, designed to treat patients with acute myocardial infarction (AMI). The Booster™ balloon is placed in the coronary sinus vein after revascularization of the occluded artery and uses its unique spiral design to increase vascular pressure, enhancing blood perfusion into the affected myocardium and improving cardiac function. The company claims that this can lead to a reduction in infarct size and improve clinical outcomes.

Intratech Medical has launched its first in-human clinical study in 2022, which has shown very promising results. The company has secured a significant investment from a key strategic corporation in the interventional cardiology field and has a comprehensive patent family with patents granted in the US, Canada, Europe, China, and Japan.

Prior to the Booster balloon, Intratech developed the NaviMax™ thrombectomy device for ischemic stroke patients, which has received CE mark approval. The management team includes CEO Amit Ashkenazi, who has over 20 years of experience in the medical device industry and has held various leadership roles, including President & CEO of Keystone Heart. Founder and CTO Eran Hirszowicz is a seasoned entrepreneur and inventor with a history of establishing successful medical device companies.

Intratech Medical's Chief Medical Officer is Prof. Giora Weisz, an interventional cardiologist and associate professor of medicine with a significant research background in innovative technologies for cardiovascular medicine. The company also has a panel of scientific advisors, including Prof. Rafael Beyar, an interventional cardiologist and biomedical engineer, and Dr. Timothy Henry, the Medical Director of The Carl and Edyth Lindner Center for Research and Education.

The company's headquarters are located in the Shefayim Commercial Center, Kibbutz Shefayim, Israel.